MRgLITT for mTLE: A PROBE Trial
ConditionTemporal Lobe Epilepsy (TLE)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorBeijing Tiantan Hospital
About this trial
How does magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) impact clinical prognosis in mesial temporal lobe epilepsy (mTLE)?
Eligibility criteria
Qualifiers
18-65 years.
Drug-resistant mesial temporal lobe epilepsy.
Seizure frequency ≥ 1 time /month.
Participants approved.
Disqualifiers
History of brain surgery.
Intracranial space occupying lesions.
Individuals with significant medical comorbidities or conditions that pose an excessive risk for surgery, such as severe cardiovascular disease, respiratory disorders, or uncontrolled systemic infections.
Trial design
Treatments tested in this trial
- Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT)
- Open Surgery
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov